State Key Laboratory of Oncology in South China Reports Findings in Artificial I ntelligence (Association of artificial intelligence-based immunoscore with the e fficacy of chemoimmunotherapy in patients with advanced non-squamous non-small c ell ...)
State Key Laboratory of Oncology in South China Reports Findings in Artificial I ntelligence (Association of artificial intelligence-based immunoscore with the e fficacy of chemoimmunotherapy in patients with advanced non-squamous non-small c ell ...)
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Artificial Intelligenc e is the subject of a report. According to newsreporting originating in Guangzh ou, People’s Republic of China, by NewsRx journalists, research stated,“Current ly, chemoimmunotherapy is effective only in a subset of patients with advanced n on-squamousnon-small cell lung cancer. Robust biomarkers for predicting the eff icacy of chemoimmunotherapy wouldbe useful to identify patients who would benef it from chemoimmunotherapy.”
Key words
Guangzhou/People’s Republic of China/A sia/Artificial Intelligence/Biomarkers/Cancer/Diagnostics and Screening/Dru gs and Therapies/Emerging Technologies/Health and Medicine/Immunology/Lung C ancer/Lung Diseases and Conditions/Lung Neoplasms/Machine Learning/Non-Small Cell Lung Cancer/Oncology/Therapy
NETL
NSTL